Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. N-(2-(bis(1-methylethyl)amino)ethyl)-2-oxo-1-pyrrolidineacetamide
2. Pramiracetam Hydrochloride
3. Pramiracetam Sulfate
4. Pramistar
1. 68497-62-1
2. Pramiracetam [inn]
3. N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
4. N-(2-(diisopropylamino)ethyl)-2-(2-oxopyrrolidin-1-yl)acetamide
5. 1-pyrrolidineacetamide, N-(2-(bis(1-methylethyl)amino)ethyl)-2-oxo-
6. 4449f8i3le
7. Pramiracetam (inn)
8. N-[2-[bis(1-methylethyl)amino]ethyl]-2-oxo-1-pyrrolidineacetamide
9. 1-pyrrolidineacetamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-oxo-
10. Pramiracetamum
11. Pramiracetamum [inn-latin]
12. Unii-4449f8i3le
13. N-(2-(bis(1-methylethyl)amino)ethyl)-2-oxo-1-pyrrolidineacetamide
14. Pramiracetam/ci-879
15. Pramiracetam [mi]
16. Ci-879 Free Base
17. Mls006010035
18. Pramiracetam [who-dd]
19. Schembl195465
20. Benzoic Acid, O-(p-toluyl)-
21. Chembl159776
22. Dtxsid60218604
23. Chebi:135110
24. Hms3656m20
25. Hms3884n10
26. Bcp27900
27. Zinc1856108
28. S2594
29. Akos005066359
30. Ac-8798
31. Ccg-267142
32. Cs-1573
33. Db13247
34. Hs-0092
35. Ncgc00346668-01
36. Ncgc00346668-04
37. Hy-17455
38. Smr004701212
39. Db-055157
40. Ft-0630777
41. P2061
42. Sw219170-1
43. C76170
44. D08405
45. Ab01566859_01
46. 497p621
47. A836161
48. Q415746
49. Q-201610
50. Z221101674
51. N-(2-(diisopropylamino)ethyl)-2-oxo-1-pyrrolidineacetamide
52. Amacetam, N-[2-(diisopropylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
53. N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxo-1-pyrrolidinyl)acetamide
54. N-{2-[bis(propan-2-yl)amino]ethyl}-2-(2-oxopyrrolidin-1-yl)acetamide
55. N-[2-[bis(1-methylethyl)amino]ethyl]-2-oxo-1-pyrrolidineacetamide, Vinpotropil
56. N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxidanylidenepyrrolidin-1-yl)ethanamide
| Molecular Weight | 269.38 g/mol |
|---|---|
| Molecular Formula | C14H27N3O2 |
| XLogP3 | 0.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 7 |
| Exact Mass | 269.21032711 g/mol |
| Monoisotopic Mass | 269.21032711 g/mol |
| Topological Polar Surface Area | 52.6 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 308 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
N - Nervous system
N06 - Psychoanaleptics
N06B - Psychostimulants, agents used for adhd and nootropics
N06BX - Other psychostimulants and nootropics
N06BX16 - Pramiracetam
ABOUT THIS PAGE
74
PharmaCompass offers a list of Pramiracetam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pramiracetam manufacturer or Pramiracetam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pramiracetam manufacturer or Pramiracetam supplier.
PharmaCompass also assists you with knowing the Pramiracetam API Price utilized in the formulation of products. Pramiracetam API Price is not always fixed or binding as the Pramiracetam Price is obtained through a variety of data sources. The Pramiracetam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pramistar manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pramistar, including repackagers and relabelers. The FDA regulates Pramistar manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pramistar API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pramistar supplier is an individual or a company that provides Pramistar active pharmaceutical ingredient (API) or Pramistar finished formulations upon request. The Pramistar suppliers may include Pramistar API manufacturers, exporters, distributors and traders.
Pramistar Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pramistar GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pramistar GMP manufacturer or Pramistar GMP API supplier for your needs.
A Pramistar CoA (Certificate of Analysis) is a formal document that attests to Pramistar's compliance with Pramistar specifications and serves as a tool for batch-level quality control.
Pramistar CoA mostly includes findings from lab analyses of a specific batch. For each Pramistar CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pramistar may be tested according to a variety of international standards, such as European Pharmacopoeia (Pramistar EP), Pramistar JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pramistar USP).
